VAZULI 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 28
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1256803630038 -
GGREM
528525090240903 -
Código de barras
7899547555462
O que a fonte publica
- Detentor do registro
- PRATI DONADUZZI & CIA LTDA
- Princípios ativos
- RIVAROXABANA
- Embalagem
- 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 28
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- B1F - INIBIDORES DIRETOS DO FATOR XA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "VAZULI 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 28",
"holder": "PRATI DONADUZZI & CIA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7899547555462"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "528525090240903",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "73.856.593/0001-66",
"priceRegime": "Regulado",
"productName": "VAZULI",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 28",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "158.05",
"icms-12": "179.60",
"icms-17": "190.42",
"icms-18": "192.74",
"icms-19": "195.12",
"icms-20": "197.56",
"icms-21": "200.06",
"icms-22": "202.63",
"icms-23": "205.26",
"icms-17.5": "191.58",
"icms-19.5": "196.34",
"icms-20.5": "198.81",
"icms-22.5": "203.94",
"icms-12-alc": "177.45",
"icms-17-alc": "188.14",
"icms-18-alc": "190.43",
"icms-19-alc": "192.78",
"icms-20-alc": "195.19",
"icms-21-alc": "197.66",
"icms-22-alc": "200.20",
"icms-23-alc": "202.80",
"withoutTaxes": "156.15",
"icms-17.5-alc": "189.28",
"icms-19.5-alc": "193.98",
"icms-20.5-alc": "196.42",
"icms-22.5-alc": "201.49"
},
"pisCofinsList": "Positiva",
"substanceText": "RIVAROXABANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "217.86",
"icms-12": "247.56",
"icms-17": "262.47",
"icms-18": "265.67",
"icms-19": "268.95",
"icms-20": "272.32",
"icms-21": "275.76",
"icms-22": "279.30",
"icms-23": "282.93",
"icms-17.5": "264.07",
"icms-19.5": "270.63",
"icms-20.5": "274.04",
"icms-22.5": "281.11",
"icms-12-alc": "245.31",
"icms-17-alc": "260.09",
"icms-18-alc": "263.26",
"icms-19-alc": "266.51",
"icms-20-alc": "269.84",
"icms-21-alc": "273.25",
"icms-22-alc": "276.76",
"icms-23-alc": "280.36",
"withoutTaxes": "215.87",
"icms-17.5-alc": "261.67",
"icms-19.5-alc": "268.17",
"icms-20.5-alc": "271.54",
"icms-22.5-alc": "278.55"
},
"invalidBarcodes": [],
"activeSubstances": [
"RIVAROXABANA"
],
"therapeuticClass": "B1F - INIBIDORES DIRETOS DO FATOR XA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1256803630038",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "B1F",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:528525090240903"